Table 4.
Number of Cases | Number % | |
---|---|---|
Regions and Reports | T-cell lymphoma | Nasal NK T-cell lymphoma |
North America, Europe, Asia8 | 1314 | 10.4 |
North America | 5.1 | |
Europe | 4.3 | |
Asia | 22.4 | |
South America, Europe, and Middle/Far East9 | 737 | 13 |
Europe | 317 | 6 |
Italy | 5 | |
United Kingdome | 4 | |
Spain, Switzerland, Slovakia | 11 | |
USA | 9 | |
South-America | 152 | 13 |
Chile | 11 | |
Brazil | 15 | |
Argentina, Uruguay | 15 | |
Middle/Far East (South Korea; Hong Kong; Israel) | 338 | 31 |
Central and South America, North America11 | 118 | 23 |
Argentina | 4 | |
Brasil | 9 | |
Chile | 22 | |
Guatemala | 66 | |
Peru | 13 | |
North America | 38 | 0 |
Europe-North America, Asia19 | 1153 | 8 |
Europe-North America | 689 | 3 |
Asia Total | 464 | 15 |
Bangkok, Thailand | 34 | |
Hong Kong, China | 21 | |
Seoul, Korea | 19 | |
Japan Total | 306 | 12 |
Tokyo, Japan | 13 | |
Nagoya, Japan | 17 | |
Okayama, Japan | 20 | |
Fukuoka, Japan | 6 |